AtaiBeckley (ATAI) Short term Debt (2021 - 2026)
AtaiBeckley's (ATAI) quarterly Short term Debt came in at $310000.0 in Q1 2026, up 14.39% quarter-over-quarter from $271000.0 in Q4 2025.
AtaiBeckley (ATAI) Short term Debt (2021 - 2026) Analysis & Trends
AtaiBeckley's Short term Debt history runs 3 years deep, the most recent figure standing at $310000.0 for Q1 2026.
- On a quarterly basis, Short term Debt changed N/A year-over-year to $310000.0 in Q1 2026; TTM through Mar 2026 was $310000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $271000.0, down 95.75% from the prior year.
- Short term Debt rose to $310000.0 in Q1 2026 per ATAI's latest filing, from $271000.0 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $161.5 million in Q3 2022 to a low of $38000.0 in Q3 2021.
- A 5-year average of $30.8 million and a median of $275000.0 in 2023 frame the typical range for Short term Debt.
- Biggest YoY gain for Short term Debt was 95.75% in 2025; the steepest drop was 95.75% in 2025.
- Year by year, Short term Debt stood at $6.4 million in 2024, then tumbled by 95.75% to $271000.0 in 2025, then increased by 14.39% to $310000.0 in 2026.
- Per Business Quant, the three latest ATAI Short term Debt figures stand at $310000.0 (Q1 2026), $271000.0 (Q4 2025), and $6.4 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 310,000.00 |
| Dec 31, 2025 | 271,000.00 |
| Sep 30, 2025 | 532,000.00 |
| Mar 31, 2025 | 11.37 Mn |
| Dec 31, 2024 | 6.37 Mn |
| Dec 31, 2024 | 6.37 Mn |
| Sep 30, 2024 | 257,000.00 |
| Jun 30, 2024 | 239,000.00 |
| Mar 31, 2024 | 244,000.00 |
| Dec 31, 2023 | 275,000.00 |
| Sep 30, 2023 | 132.50 Mn |
| Jun 30, 2023 | 86.40 Mn |
| Sep 30, 2022 | 161.50 Mn |
| Dec 31, 2021 | 51,000.00 |
| Sep 30, 2021 | 38,000.00 |
| Jun 30, 2021 | 39,000.00 |